Medical products for Ebola
With early diagnosis and correct treatment, patients infected with Ebola have a good chance of survival. With proper precautions, the risk of Ebola spreading can be mitigated. Early diagnosis, treatment and containment require medicines and medical devices which can be of limited supply in countries with scarce resources. The Department of Essential Medicines an Health Products will be providing information resources as they become available, to meet the medical product needs for the Ebola response.
During the 2012–2013 biennium, WHO assisted more than 100 countries in the formulation and implementation of national policies and strategies for improving evidence-based selection and rational use of essential medical products, and supported over 120 countries to develop national plans and build capacities to regulate and ensure the quality and safety of medicines, diagnostics, medical devices, vaccines and biologicals. These efforts have been guided by the third WHO Medicines Strategy 2008–2013 and by requests from Member States for support in implementing actions agreed to in World Health Assembly and Executive Board resolutions.
The International Conference of Drug Regulatory Authorities (ICDRAs) provide drug regulatory authorities of WHO Member States with a forum to meet and discuss ways to strengthen collaboration. The ICDRAs have been instrumental in guiding regulatory authorities, WHO and interested stakeholders and in determining priorities for action in national and international regulation of medicines, vaccines, biomedicines and herbals.
A partnership between the European Union (EU), the African, Caribbean and Pacific countries (ACP) and the World Health Organization (WHO) opened a three-day meeting in Harare on 24 June to review progress on improving the pharmaceutical sector in 15 African countries to increase access to medicines. The meeting brings together officials and medicines experts from 15 African countries, WHO, the EU and other partners. The Minister of Health and Childcare of Zimbabwe, the Honourable Dr. David Parirenyatwa, officially opened the meeting at at the Meikles Hotel in downtown Harare.
Essential Medicines and Health Products (EMP)
Our vision is that people everywhere have access to the essential medicines and health products they need; that the medicines and health products are safe, effective and of assured quality; and that medicines are prescribed and used rationally and that medical devices are used and managed effectively.
Visit "'About us'" to learn more.